ArcticZymes Technologies falls short of guidance

05 Jan 2023 07:40 CET

Tromsø, January 05 2023 - ArcticZymes Technologies ASA (OSE: AZT) announces
significant headwinds for the fourth quarter with sales of 28.3 MNOK and 137.2
MNOK for the fiscal year 2022.

ArcticZymes Technologies fell short in the fourth quarter generating 28.3 MNOK
in product sales. The shortfall impacted the Company´s annual sales guidance
target of 155 MNOK and resulted in an underperformance of 137.2 MNOK for the
full year 2022. The combination of reduced demand post-pandemic and the impact
of the macroeconomic environment have reduced turnover within the Molecular
Tools business. Quarterly sales for the Molecular Tools business were 9.2 MNOK.

Sales in the Biomanufacturing business were unaffected and continued to grow in
accordance with expectations. Quarterly sales for the Biomanufacturing business
were 19.1 MNOK.

ArcticZymes Technologies ASA, CEO, Jethro Holter said:

"After a few years of continued growth, profitable performance and milestone
achievements, 2022 fell short of its guidance to the market. Entering 2023, the
macro-economic effect will continue to impact the Molecular Tools business but
less likely the Biomanufacturing business. Despite the current headwinds, the
Company remains optimistic towards the future and expects continued growth in
the coming years."

For more information, please contact:

CEO, Jethro Holter Tel: +47 46 85 91 46
CFO, Børge Sørvoll Tel: +47 95 29 01 87
ir@arcticzymes.com

About ArcticZymes Technologies ASA

ArcticZymes Technologies is a Norwegian life sciences company focused on the
development, manufacturing and commercialization of novel recombinant enzymes
for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing.

Listed on the Oslo Stock Exchange since 2005 as ArcticZymes Technologies under
the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at the SIVA
Innovation Centre.

ArcticZymes Technologies' IP and capabilities are protected via a large
portfolio of patents.

For more information, please visit the website: www.arcticzymes.com.

The information included in this release is defined as inside information in
accordance with the EU Market Abuse Regulation and is subject to the disclosure
requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

The announcement was submitted for publication by Børge Sørvoll ,CFO at
ArcticZymes Technologies ASA, on 5 January 2023 at 07:40 CET.

More information:
Access the news on Oslo Bors NewsWeb site

579641_AZT_Sales_lower_than_guidance_05012023.pdf